摘要
目的:探究半夏泻心汤联合西医治疗在幽门螺杆菌感染初治患者中的综合应用价值。方法:选取2018年10月-2020年5月90例幽门螺杆菌感染初治患者为研究对象,将其随机分为对照组(西医治疗组)和观察组(半夏泻心汤联合西医治疗组),每组45例。比较两组Ⅰ、Ⅱ型患者及整组的临床总有效率、幽门螺杆菌根除率、不良反应发生率、治疗前、治疗1、2周后的症状体征积分。结果:观察组的临床总有效率及幽门螺杆菌根除率均显著高于对照组,差异有统计学意义(P<0.05),治疗前两组的症状体征积分比较,差异无统计学意义(P>0.05),治疗1、2周后观察组的症状体征积分均显著低于对照组,差异有统计学意义(P<0.05),两组的不良反应发生率比较,差异无统计学意义(P>0.05)。结论:半夏泻心汤联合西医治疗在幽门螺杆菌感染初治患者中的应用效果较好,安全性值得肯定,因此其在本类患者中的综合应用价值相对较高。
Objective:To explore the comprehensive application value of Banxia Xiexin Decoction combined with western medicine treatment in initial treatment of patients with Helicobacter pylori infection.Method:A total of 90 initial treatment of patients with Helicobacter pylori infection from October 2018 to May 2020 were chosen as the study object,and they were randomly divided into control group(western medicine treatment group)and observation group(Banxia Xiexin Decoction combined with western medicine treatment group),with 45 cases in each group.Then the total clinical effective rate between the two groups of typeⅠandⅡpatients and the whole group was compared,the eradication rate of Helicobacter pylori,incidence of adverse reactions,symptom and sign scores before treatment and 1,2 weeks after treatment of two groups were compared.Result:The total clinical effective rate and eradication rate of helicobacter pylori of observation group were significantly higher than those of control group,there were statistically significant differences(P<0.05),the symptom and sign scores of two groups before the treatment were compared,there were no statistically significant differences(P>0.05),the symptom and sign scores of observation group 1,2 weeks after the treatment were significantly lower than those of the control group,there were statistically significant differences(P<0.05),the incidence adverse reactions of two groups were compared,there were no statistically significant differences(P>0.05).Conclusion:The application effect of Banxia Xiexin Decoction combined with western medicine treatment in initial treatment of patients with Helicobacter pylori infection is better,and the safety is worth affirming,so its comprehensive application value in these patients is relatively higher.
作者
邱建钊
QIU Jianzhao(Sanming First Hospital,Sanming 365000,China)
出处
《中外医学研究》
2021年第29期150-153,共4页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
半夏泻心汤
西医治疗
幽门螺杆菌感染
初治
综合应用价值
Banxia Xiexin Decoction
Western medicine treatment
Helicobacter pylori infection
Initial treatment
Comprehensive application value